複製鏈接
請複製以下鏈接發送給好友
https://baike.baidu.hk/item/張墨/23622014
複製
複製成功

張墨

（中國醫科大學附屬第一醫院泌尿外科醫師）

鎖定
張墨，男，中國醫科大學附屬第一醫院，泌尿外科 [1]  ，副教授，副主任醫師 [2]  。
泌尿外科學博士，美國加州大學洛杉磯分校UCLA博士後。現任遼寧省泌尿外科分會尿控學組委員，共發表40餘篇學術論文 [3]  。瀋陽市“五一勞動獎章”獲得者，瀋陽市高校青年教師教學楷模 [2]  [4]  。
中文名
張墨
外文名
Mo Zhang
國    籍
中國
畢業院校
中國醫科大學 [5] 
學    歷
博士研究生 [5] 
教學職稱
副教授 [2] 
臨牀職稱
副主任醫師 [2] 
執業地點
中國醫科大學附屬第一醫院 [1] 
職    業
醫生
專    業
泌尿外科

目錄

  1. 1 學術兼職
  2. 2 獲獎情況
  3. 3 科研成果

張墨學術兼職

遼寧省泌尿外科分會尿控學組委員

張墨獲獎情況

  1. 全國中青年泌尿外科醫師臨牀技能大賽一等獎 [6] 
  2. 第四屆全國高等醫學院校青年教師教學基本功大賽二等獎 [7] 
  3. 瀋陽市高校教師基本功大賽第一名 [4] 

張墨科研成果

  1. Zhang M, Kobayashi N, Zettlitz KA, Kono EA, Yamashiro JM, Tsai WK, Jiang ZK, Tran CP, Wang C, Guan J, Wu AM, Reiter RE. Near-infrared-dye labeled anti-Prostate Stem Cell Antigen minibody enables real-time fluorescence imaging and targeted surgery in translational mouse models. Clin Cancer Res, 2019;25(1):188-200. [8] 
  2. Zhang M, Guan J, Huo Y, Song Y, Chen L. Downregulation of serum CXCL4L1 predicts progression and poor prognosis in prostate cancer patients treated by radical prostatectomy. Asian J Androl, 2019, 21(4):387-392. [9] 
  3. Chen L, Guan J, Wei Q, Yuan Z, Zhang M. Potential role of "omics" technique in prenatal diagnosis of congenital heart defects. Clin Chim Acta, 2018 Jul;482:185-190. [10] 
  4. Zhang M, Chen L, Yuan Z, Yang Z, Li Y, Shan L, Yin B, Fei X, Miao J, Song Y. Combined serum and EPS-urine proteomic analysis using iTRAQ technology for discovery of potential prostate cancer biomarkers. Discov Med, 2016,22(122):281-295. [11] 
  5. Zhang M, Wang K, Chen L, Yin B, Song Y. Is phytoestrogen intake associated with decreased risk of prostate cancer? A systematic review of epidemiological studies based on 17,546 cases. Andrology, 2016,4(4):745-756. [12] 
  6. Chen L, Zhang E, Guan J, Chen Z, Ye J, Liu W, He J, Yin B, Song Y, Zhang M*. A Combined CRISP3 and SPINK1 Prognostic Grade in EPS-Urine and Establishment of Models to Predict Prognosis of Patients With Prostate Cancer. Front. Med. 2022 Feb 17; 9:832415. [17] 
  7. Zhang E, Shiori F, Mu O, He J, Zhang H, GE Y, Wu H, Zhang M* , Song Y* . Establishment of novel DNA methylation-based prostate cancer subtypes and a risk-predicting eight-gene signature. Front Cell Dev Biol, 2021 Feb 23; DOI:10.3389/fcell.2021.639615. [16] 
  8. Zhang E, Hou X, Hou B, Zhang M* , Song Y* . A risk prediction model of DNA methylation improves prognosis evaluation and indicates gene targets in prostatecancer. Epigenomics, 2020,12(4): 333-352. [18] 
  9. Zhang E, He J, Zhang H, Shan L, Wu H, Zhang M* , Song Y* . Immune-Related Gene-Based Novel Subtypes to Establish a Model Predicting the Risk of Prostate Cancer. Front Genet, 2020 Nov 13;11: 595657. [19] 
  10. Li D, Hao X, Dong Y, Zhang M*, Song Y. PF4V1, an miRNA-875-3p target, suppresses cell proliferation, migration, and invasion in prostate cancer and serves as a potential prognostic biomarker. Cancer Manag Res, 2019, 21(11):2299-2312. [20] 
  11. Chen L, Guan J, Gu H, Zhang M*. Outcomes in fetuses diagnosed with megacystis: Systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2019 Feb, 233:120-126. [21] 
  12. 張墨, 費翔, 卜仁戈, 等. 應用TUR術治療膀胱癌膀胱全切術後複發性尿道癌[J]. 現代腫瘤醫學, 2013, 21(10):2266-2268. [13] 
  13. 張墨, 王鵬, 殷波, 等. 經直腸剪切波彈性成像技術聯合移行區穿刺在前列腺癌診斷中的應用價值[J]. 中華男科學雜誌，2015, 21(7):610-614. [14] 
  14. 張墨, 陳驪珠, 宋永勝, 等. 定量蛋白質組學技術篩選前列腺癌患者尿液中差異表達蛋白價值[J]. 中華實用診斷與治療雜誌, 2018, 32(2):109-112. [15] 
參考資料
展開全部 收起